Zhao J, Zhao L, Guo W, Wang S, et al. Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Camrelizumab and Apatinib in Patients with Resectable Non-Small-Cell Lung Cancer: A Phase 2 Clinical Trial. J Thorac Oncol 2023 Mar 2:S1556-0864(23)00161.
PMID: 36870519